Prescriptions of chinese herbal medicine for constipation under the National Health Insurance in Taiwan

Journal of the Chinese Medical Association

Volumn 73, Issue 7, 2010, Pages 375-383

  Jong, Maw Shiou ^a,d   Hwang, Shinn Jang ^a,c   Chen, Yu Chun ^a,c   Chen, Tzeng Ji ^a,c   Chen, Fun Jou ^b   Chen, Fang Pey ^a,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Section of General Medicine   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chinese herbal medicine; Constipation; Pharmacoepidemiology; Traditional Chinese medicine

Indexed keywords

ANGELICA SINENSIS EXTRACT; ATRACTYLODES EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; CANNABIS; CINNAMOMUM CASSIA EXTRACT; COPTIS CHINENSIS EXTRACT; CYPERUS ROTUNDUS EXTRACT; EPHEDRA SINICA EXTRACT; GARDENIA JASMINOIDES EXTRACT; GINGER EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HERBACEOUS AGENT; LIGUSTICUM CHUANXIONG EXTRACT; MAGNOLIA OFFICINALIS EXTRACT; PAEONIA LACTIFLORA EXTRACT; PHELLODENDRON AMURENSE EXTRACT; PLATYCODON GRANDIFLORUM EXTRACT; REHMANNIA GLUTINOSA EXTRACT; RHUBARB EXTRACT; SAUSSUREA LAPPA EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; SOUR ORANGE EXTRACT;

ADULT; APRICOT; ARTICLE; CHINESE HERB; CHINESE MEDICINE; CONSTIPATION; FEMALE; HERBAL MEDICINE; HUMAN; IPOMOEA NIL; LOQUAT; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PRESCRIPTION; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; CONSTIPATION; DRUG PRESCRIPTIONS; DRUG UTILIZATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; TAIWAN;

EID: 77955265433     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(10)70081-2     Document Type: Article

References (47)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
2. Lu CL, Chang FY, Chen CY, Luo JC, Lee SD Significance of Rome II-defined functional constipation in Taiwan and comparison with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2006, 24:429-438.
3. Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 2008, 8:5.
4. Johanson JF Review of the treatment options for chronic constipation. Medgenmed [Computer file]. MedGenMed 2007, 9:25.
5. Bharucha AE Constipation. Best Pract Res Clin Gastroenterol 2007, 21:709-731.
6. Chen FP, Chen TJ, Kung YY, Chen YC, Chou LF, Chen FJ, Hwang SJ Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res 2007, 7:26.
7. Cheng SH, Chiang TL The effect of universal health insurance on health care utilization in Taiwan: results from a natural experiment. JAMA 1997, 278:89-93.
8. Bureau of National Health Insurance, Department of Health, Executive Yuan, R.O.C [Date accessed: August 10, 2005]. http://www.nhi.gov.tw/webdata/webdata.asp?menu=1&menu_id=4&webdata_id=1399&WD_ID=
9. Berry MJ, Linoff G Data Mining Techniques: For Marketing Sales, and Customer Support 1997, Welly Press, New York.
10. Han J, Kamber M Data Mining: Concepts and Techniques 2001, Morgan Kaufmann Press, San Francisco.
11. Chen TJ, Chou LF, Hwang SJ Application of a data-mining technique to analyze coprescription patterns for antacids in Taiwan. Clin Ther 2003, 25:2453-2463.
12. Chiarelli P, Brown W, McElduff P Constipation in Australian women: prevalence and associated factors. Int Urogynecol J 2000, 11:71-78.
13. Higgins PD, Johanson JF Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004, 99:750-759.
14. Xiao P, He L, Wang L Ethnopharmacologic study of Chinese rhubarb. J Ethnopharmacol 1984, 10:275-293.
15. Ewe K The physiological basis of laxative action. Pharmacology 1980, 20(Suppl):2-20.
16. Heizer WD, Sandler RS, Seal E, Murray SC, Busby MG, Schliebe BG, Pusek SN Intestinal effects of sulfate in drinking water on normal human subjects. Dig Dis Sci 1997, 42:1055-1061.
17. Tsai JC, Tsai S, Chang WC Comparison of two Chinese medical herbs, Huangbai and Qianniuzi, on influence of short circuit current across the rat intestinal epithelia. J Ethnopharmacol 2004, 93:21-25.
18. Gilani AH, Aziz N, Ali SM, Saeed M Pharmacological basis for the use of peach leaves in constipation. J Ethnopharmacol 2000, 73:87-93.
19. Xie DP, Chen LB, Liu CY, Zhang CL, Liu KJ, Wang PS Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits. Chin J Physiol 2004, 47:89-94.
20. Deng S, Chen SN, Yao P, Nikolic D, van Breemen RB, Bolton JL, Fong HH, et al. Serotonergic activity-guided phytochemical investigation of the roots of Angelica sinensis. J Nat Prod 2006, 69:536-541.
21. Galligan JJ, Vanner S Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 2005, 17:643-653.
22. Tian YY, An LJ, Jiang L, Duan YL, Chen J, Jiang B Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures. Life Sci 2006, 80:193-199.
23. Tundis R, Loizzo MR, Menichini F, Statti GA, Menichini F Biological and pharmacological activities of iridoids: recent developments. Mini Rev Med Chem 2008, 8:399-420.
24. Yamauchi K, Fujimoto N, Kuwano S, Inouye H, Inoue K The mechanism of purgative action of geniposide, an iridoid glucoside of the fruit of Gardenia, in mice. Planta Med 1976, 30:39-47.
25. Mehendale S, Aung H, Wang CZ, Tong R, Foo A, Xie JT, Yuan CS Scutellaria baicalensis and a constituent flavonoid, baicalein, attenuate ritonavir-induced gastrointestinal side-effects. J Pharm Pharmacol 2007, 59:1567-1572.
26. Yamahara J, Huang QR, Li YH, Xu L, Fujimura H Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull 1990, 38:430-431.
27. Huang YL, Yen GC, Sheu F, Chau CF Effects of water-soluble carbohydrate concentrate from Chinese jujube on different intestinal and fecal indices. J Agric Food Chem 2008, 56:1734-1739.
28. Capasso R, Borrelli F, Aviello G, Romano B, Scalisi C, Capasso F, Izzo AA Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice. Br J Pharmacol 2008, 154:1001-1008.
29. De Filippis D, Iuvone T, D'Amico A, Esposito G, Steardo L, Herman AG, Pelckmans PA, et al. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB(1) receptors and fatty acid amide hydrolase. Neurogastroenterol Motil 2008, 20:919-927.
30. Uddin SJ, Mondal K, Shilpi JA, Rahman MT Antidiarrhoeal activity of Cyperus rotundus. Fitoterapia 2006, 77:134-136.
31. Sato Y, Akao T, He JX, Nojima H, Kuraishi Y, Morota T, Asano T, et al. Glycycoumarin from Glycyrrhizae Radix acts as a potent antispasmodic through inhibition of phosphodiesterase 3. J Ethnopharmacol 2006, 105:409-414.
32. Chan SS, Zhao M, Lao L, Fong HH, Che CT Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum. Planta Med 2008, 74:381-384.
33. Grigoleit HG, Grigoleit P Gastrointestinal clinical pharmacology of peppermint oil. Phytomedicine 2005, 12:607-611.
34. Yang HO, Ko WK, Kim JY, Ro HS Paeoniflorin: an antihyperlipidemic agent from Paeonia lactiflora. Fitoterapia 2004, 75:45-49.
35. Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005, 2. CD003460.
36. Gilani AH, Shah AJ, Yaeesh S Presence of cholinergic and calcium antagonist constituents in Saussurea lappa explains its use in constipation and spasm. Phytother Res 2007, 21:541-544.
37. Chang Q, Zuo Z, Harrison F, Chow MS Hawthorn. J Clin Pharmacol 2002, 42:605-612.
38. Akagiri S, Naito Y, Ichikawa H, Mizushima K, Takagi T, Handa O, Kokura S, et al. Bofutsushosan, an oriental herbal medicine, attenuates the weight gain of white adipose tissue and the increased size of adipocytes associated with the increase in their expression of uncoupling protein 1 in high-fat diet-fed male KK/Ta mice. J Clin Biochem Nutr 2008, 42:158-166.
39. Saegusa Y, Sugiyama A, Takahara A, Nagasawa Y, Hashimoto K Relationship between phosphodiesterase inhibition induced by several Kampo medicines and smooth muscle relaxation of gastrointestinal tract tissues of rats. J Pharmacol Sci 2003, 93:62-68.
40. Riedlinger JE, Tan PW, Lu W Ping wei san, a Chinese medicine for gastrointestinal disorders. Ann Pharmacother 2001, 35:228-235.
41. Hatanaka N, Yamagishi T, Kamemura H, Nakazawa I, Hirano Y, Hosaka K, Sanno K, et al. A case of hepatitis and pneumonitis caused by Bofutsusyo-san herbal medicine. Nihon Kokyuki Gakkai Zasshi 2006, 44:335-339. [In Japanese].
42. Ikegami F, Sumino M, Fujii Y, Akiba T, Satoh T Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Hum Exp Toxicol 2006, 25:481-494.
43. Xie H, Morikawa T, Matsuda H, Nakamura S, Muraoka O, Yoshikawa M Monoterpene constituents from Cistanche tubulosa: chemical structures of kankanosides A-E and kankanol. Chem Pharm Bull 2006, 54:669-675.
44. Kase Y, Hayakawa T, Ishige A, Aburada M, Komatsu Y The effects of Hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of rats. Biol Pharm Bull 1997, 20:954-957.
45. Ai M, Yamaguchi T, Odaka T, Mitsuhashi K, Shishido T, Yan J, Seza A, et al. Objective assessment of the antispasmodic effect of shakuyaku-kanzo-to (TJ-68), a Chinese herbal medicine, on the colonic wall by direct spraying during colonoscopy. World J Gastroenterol 2006, 12:760-764.
46. Chen FP, Chen FJ, Jong MS, Tsai HL, Wang JR, Hwang SJ Modern use of Chinese herbal formulae from Shang-Han Lun. Chin Med J 2009, 122:1889-1894.
47. Cheng CW, Bian ZX, Wu TX Systematic review of Chinese herbal medicine for functional constipation. World J Gastroenterol 2009, 15:4886-4895.